A Atovaquone, Proguanil Hydrochloride CEP of the European Pharmacopoeia monograph is often referred to as a Atovaquone, Proguanil Hydrochloride Certificate of Suitability (COS). The purpose of a Atovaquone, Proguanil Hydrochloride CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Atovaquone, Proguanil Hydrochloride EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Atovaquone, Proguanil Hydrochloride to their clients by showing that a Atovaquone, Proguanil Hydrochloride CEP has been issued for it. The manufacturer submits a Atovaquone, Proguanil Hydrochloride CEP (COS) as part of the market authorization procedure, and it takes on the role of a Atovaquone, Proguanil Hydrochloride CEP holder for the record. Additionally, the data presented in the Atovaquone, Proguanil Hydrochloride CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Atovaquone, Proguanil Hydrochloride DMF.
A Atovaquone, Proguanil Hydrochloride CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Atovaquone, Proguanil Hydrochloride CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Atovaquone, Proguanil Hydrochloride suppliers with CEP (COS) on PharmaCompass.